✦ LIBER ✦

Secular Changes in Published Clinical Trials of Second-Line Agents in Rheumatoid Arthritis

✍ Scribed by Jennifer J. Anderson; David T. Felson; Robert F. Meenan

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 587 KB
Volume: 34
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780341015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secular changes in the quality of publis

Secular changes in the quality of published randomized clinical trials in rheumatology

✍ Catherine L. Hill; Michael P. LaValley; David T. Felson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

## Abstract ## Objective To assess the quality of published randomized clinical trials (RCTs) in rheumatology and to determine whether there has been improvement in quality between 2 time periods, 1987–1988 and 1997–1998. ## Methods Using MEDLINE and a hand search of selected rheumatology journa

Use of short-term efficacy/toxicity trad

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

✍ David T. Felson; Jennifer J. Anderson; Robert F. Meenan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

Clinical Trial of Penicillamine in Rheum

Clinical Trial of Penicillamine in Rheumatoid Arthritis

✍ Norman O. Rothermich; Marvin H. Thomas; Vol K. Phillips; Waldemar Bergen 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

## Abstract The medical records of our first 200 consecutive rheumatoid arthritis patients treated with penicillamine were analyzed retrospectively. All but 5 patients (97.5%) had undergone earlier chrysotherapy that resulted in either therapeutic failure or toxicity. Only 57 patients (28.5%) were

Time for changes in the design, analysis

Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials

✍ David T. Felson; Jennifer J. Anderson; Robert F. Meenan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 910 KB

The randomized, controlled clinical trial has become the standard approach to evaluating the efficacy of slow-acting drugs in the treatment of rheumatoid arthritis (RA). Such trials, which were used as far back as the 1940s to evaluate antimalarial agents and gold and as recently as 1988 to evaluate

Which traditional measures should be use

Which traditional measures should be used in rheumatoid arthritis clinical trials?

✍ Biostatistics Jennifer J. Anderson; Associate Professor of Medicine David T. Fel 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 686 KB

The importance of reporting disease acti

The importance of reporting disease activity states in rheumatoid arthritis clinical trials

✍ Daniel Aletaha; Julia Funovits; Josef S. Smolen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views